Form 4: Hims & Hers CFO Sells Shares After Option Exercise

Hims & Hers Health, Inc. CFO Oluyemi Okupe exercised stock options and subsequently sold 23,187 shares of Class A Common Stock for approximately $36.81 per share.

Summary

• Oluyemi Okupe, Chief Financial Officer of Hims & Hers Health, Inc. (HIMS), executed transactions on November 17, 2025.
• Transactions included the exercise of 7,615 stock options at an exercise price of $11.53 per share and 15,572 stock options at an exercise price of $5.01 per share.
• Following the option exercises, 23,187 shares of Class A Common Stock were sold at an average weighted price of $36.809 per share, with prices ranging from $36.53 to $37.25.
• All reported stock option exercises and sales were conducted pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025.
• After these transactions, Oluyemi Okupe directly beneficially owns 70,232 shares of Class A Common Stock and indirectly owns 7,853 shares through the Oluyemi Okupe Separate Property Trust dtd 9-1-2021.
• Remaining derivative securities include 48,554 stock options with an exercise price of $11.53 and 158,808 stock options with an exercise price of $5.01.

Sentiment

Score: 6

Explanation: The sentiment is moderately positive. While insider selling can sometimes be viewed negatively, the transactions were pre-planned under a 10b5-1 plan, mitigating concerns of opportunistic selling. The CFO realized significant value from options, indicating a successful compensation event.

Positives

• The Chief Financial Officer realized significant value from previously granted stock options, with shares sold at an average price of $36.809, substantially higher than the exercise prices of $11.53 and $5.01.
• The transactions were executed under a pre-arranged Rule 10b5-1 trading plan, indicating a planned liquidity event rather than an opportunistic sale based on immediate non-public information.

Negatives

• Insider selling, even when pre-planned, can sometimes be perceived negatively by investors, potentially signaling a lack of further upside or a desire for liquidity by a key executive.

Future Outlook

This filing does not contain forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This insider transaction report reflects a routine liquidity event for a corporate officer and does not provide specific insights into broader industry trends or competitive positioning.

Related Party Transactions

• 7,853 shares of Class A Common Stock are indirectly held by the Oluyemi Okupe Separate Property Trust dtd 9-1-2021, which is a related party to the reporting person.

Stakeholder Impact

• Shareholders may note the sale of shares by a key executive, which could be interpreted in various ways, though the pre-planned nature under a 10b5-1 plan typically reduces negative speculation.

Key Dates

Keywords

Hims & Hers Health, HIMS, Oluyemi Okupe, CFO, Stock Option Exercise, Insider Sale, Form 4, Rule 10b5-1 Plan, Equity Transaction